Innoscripta (1INN) Q4 2025 TU earnings summary

Executive summary

• Achieved strong revenue and EBIT growth in 2025, driven by enterprise client wins, product innovation, and process optimization.

• Expanded enterprise client base and enhanced product offerings, including AI-driven features and international no-code solutions.

• Management remains committed to long-term growth, maintaining significant ownership, supporting shareholders, and reinforcing commitment post-IPO.

• Preliminary, unaudited results indicate improved operating performance year-over-year.

Financial highlights

• Revenue grew to €104 million in 2025, up nearly 60% year-over-year, with EBIT reaching €63.6 million and an EBIT margin of 61.1%.

• Operating/free cash flow improved to €41 million, reflecting better cash collection and efficiency.

• Sales and marketing spend was over €19 million, stable at 18.5–19% of revenue.

• R&D expenditure nearly doubled to €6.6 million, representing 6.4–6.6% of revenue.

• G&A costs rose to €15.2 million, improving as a percentage of revenue to 14.6%.

Outlook and guidance

• Confident in achieving consensus revenue growth of nearly 40% for the year ahead, with formal guidance to be provided at the annual shareholder meeting.

• Management expects to maintain high margins and invest in international growth, with a new operating system environment planned for 2026.

• Final audited results for 2025 will be published on February 20, 2026, along with 2026 guidance.